Tarik Derrough

ORCID: 0000-0002-9558-0524
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Herpesvirus Infections and Treatments
  • Vaccine Coverage and Hesitancy
  • Virology and Viral Diseases
  • Viral Infections and Outbreaks Research
  • Viral gastroenteritis research and epidemiology
  • COVID-19 epidemiological studies
  • Mobile Health and mHealth Applications
  • Influenza Virus Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Viral Infections and Immunology Research
  • Bartonella species infections research
  • Hepatitis Viruses Studies and Epidemiology
  • Immune responses and vaccinations
  • Respiratory viral infections research
  • Syphilis Diagnosis and Treatment
  • Celiac Disease Research and Management
  • Disaster Response and Management
  • ICT in Developing Communities
  • Viral Infections and Vectors
  • Polyomavirus and related diseases
  • Bacterial Infections and Vaccines
  • Parvovirus B19 Infection Studies
  • T-cell and Retrovirus Studies
  • Acne and Rosacea Treatments and Effects
  • Zoonotic diseases and public health

European Centre for Disease Prevention and Control
2014-2024

World Health Organization
2016

World Health Organization - Pakistan
2016

Sanofi (France)
2007-2011

CHU Dijon Bourgogne
2007

During public health crises such as the recent outbreaks of Ebola virus disease in West Africa, breakdowns systems can lead to epidemics vaccine-preventable diseases. We report here on an outbreak measles prefecture Lola, Guinea, which started January 2015.

10.3201/eid2206.151652 article EN cc-by Emerging infectious diseases 2016-04-25

Immunisation Information Systems (IIS) are computerised confidential population based-systems containing individual-level information on vaccines received in a given area. They benefit individuals directly by ensuring vaccination according to the schedule and they provide vaccine providers public health authorities responsible for delivery monitoring of an immunisation programme. In 2016, European Centre Disease Prevention Control (ECDC) conducted survey level implementation functionalities...

10.2807/1560-7917.es.2017.22.17.30519 article EN cc-by Eurosurveillance 2017-04-27

Background. The consequences of the epidemiology varicella for zoster are still debated. We therefore compared frequency herpes in an adult population with virtually no virus (VZV) exposure that general (GP).

10.1093/cid/cir436 article EN Clinical Infectious Diseases 2011-08-15

During the Ebola outbreak in Guinea, community resistance obstructed case investigation and response. We investigated a cluster of cases that were hiding forest, refusing external help, to identify sociocultural determinants related resistance.Participant observation, interviews focus group discussions carried out.Most villagers feared treatment centre (ETC) as there was belief people killed ETCs for organ trade. Four survivors accompanied back village from ETC shared their experiences...

10.1093/inthealth/ihw018 article EN International Health 2016-04-07

EU Decision 1082/2013/EU on serious cross-border health threats provides a legal basis for collaboration between Member States, and international European level institutions preparedness, prevention, mitigation in the event of public emergency. The context present study, which aims to identify good practices lessons learned preparedness response Middle East Respiratory Syndrome (MERS) (in UK, Greece, Spain) poliomyelitis Poland Cyprus). Based documentary review, followed by five week-long...

10.1186/s12913-018-3326-0 article EN cc-by BMC Health Services Research 2018-07-06

A measles outbreak occurred in February 2014 on a ship cruising the western Mediterranean Sea. Overall 27 cases were reported: 21 crew members, four passengers.For two status or passenger was unknown. Genotype B3 identified. Because of different nationalities and persons board,the event qualified as cross-border health threat. The Italian Ministry Health coordinated rapid response.Alerts posted through Early Warning Response System.

10.2807/1560-7917.es2014.19.10.20735 article EN cc-by Eurosurveillance 2014-03-13

To monitor relative vaccine effectiveness (rVE) against COVID-19-related hospitalisation of the first, second and third COVID-19 booster (vs complete primary vaccination), we performed monthly Cox regression models using retrospective cohorts constructed from electronic health registries in eight European countries, October 2021–July 2023. Within 12 weeks administration, each showed high rVE (≥ 70% for boosters). However, as July 2023, most benefit has waned, particularly persons ≥...

10.2807/1560-7917.es.2024.29.1.2300670 article EN cc-by Eurosurveillance 2024-01-04

By employing a common protocol and data from electronic health registries in Denmark, Navarre (Spain), Norway Portugal, we estimated vaccine effectiveness (VE) against hospitalisation due to COVID-19 individuals aged ≥ 65 years old, without previous documented infection, between October 2021 March 2022. VE was higher 65-79-year-olds compared with 80-year-olds those who received booster were primary vaccinated. remained high (ca 80%) 12 < 24 weeks after the first administration, Omicron...

10.2807/1560-7917.es.2022.27.30.2200551 article EN cc-by Eurosurveillance 2022-07-28

There are up to 19.4 million children who still unvaccinated and face unnecessary deaths, especially among refugees. However, growing access smartphones, refugees, can be a leading factor improve vaccination rates.This study aims determine whether smartphone app the uptake refugees app's effectiveness in improving documentation of records.We developed planned test an through cluster randomized trial that will carried out at Zaatari refugee camp Jordan. The open all parents carry Android have...

10.2196/13557 article EN cc-by JMIR Research Protocols 2019-04-29

One Health is receiving attention for arbovirus infection prevention and control defining national "intersectoral" priorities. Increasing awareness of intersectoral priorities through multisectorial risk assessments (MRA) promising, where data are not systematically shared between sectors. Towards this aim, the MediLabSecure project organized three MRA exercises (hereby called exercises): one on West Nile virus, Crimean-Congo haemorrhagic fever, Rift Valley assessing added value approach.The...

10.1155/2020/4832360 article EN cc-by BioMed Research International 2020-04-21

Despite high COVID-19 vaccine coverage in the EU/EEA, there are increasing reports of SARS-CoV-2 infections and hospitalisations vaccinated individuals. Using surveillance data from Estonia, Ireland, Luxembourg Slovakia (January-November 2021), we estimated risk reduction severe outcomes cases. Increasing age remains most important driver severity, vaccination significantly reduces all ages for hospitalisation (adjusted relative (aRR): 0.32; 95% confidence interval (CI): 0.26-0.39) death...

10.2807/1560-7917.es.2022.27.7.2200060 article EN cc-by Eurosurveillance 2022-02-17

On 11 May 2015, the Dubréka prefecture, Guinea, reported nine laboratory-confirmed cases of Ebola virus disease (EVD). None could be epidemiologically linked to previously in prefecture. We describe epidemiological and molecular investigations this event. used EVD registers treatment centre's (ETC) records characterise chains transmission. Real-time field sequencing was employed support results. An cluster 32 found, which 27 were laboratory confirmed, 24 isolated 20 died. viral on 12...

10.2807/1560-7917.es.2018.23.12.17-00140 article EN cc-by Eurosurveillance 2018-03-22
Coming Soon ...